ProveIt Supplements

Independent, evidence-based supplement analysis.

✓ Not Sponsored

✓ No Paid Reviews

✓ Science-Based

Company

  • About Us
  • Our Methodology
  • Contact
  • Blog
  • Authors

Legal

  • Privacy Policy
  • Terms of Service
  • Medical Disclaimer
  • Affiliate Disclosure

Resources

  • All Categories
  • Ingredient Database
  • Browse Supplements
  • FAQ

© 2025 ProveIt Supplements. All rights reserved.

Medical Disclaimer: The information provided is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any supplement regimen.

Prove It
Browse SupplementsBlogAuthorsAboutMethodologyFAQ
Get Your Personalized Supplement StackSupplement Stack Quiz
Menu
HomeBrowse SupplementsBlogAuthorsAboutMethodologyFAQ
Back

Pomegranate Pericarp Extract

Also known as: Punica granatum L., Pomegranate, Pomegranate peel extract, Pomegranate pericarp extract, Punica granatum

Overview

Pomegranate pericarp extract is derived from the peel of the pomegranate fruit (*Punica granatum* L.). It is a rich source of polyphenols, including punicalagins and ellagic acid, known for their antioxidant properties. This extract is primarily used for its potential antioxidant, anti-inflammatory, and anti-aging effects. Research suggests it may also support cardiovascular and metabolic health. While numerous in vitro and animal studies support these benefits, human clinical data are still emerging. The extract's high polyphenol content contributes to its notable antioxidant capacity. It is available in various forms, with standardized extracts preferred for consistent dosing. More large-scale, long-term human trials are needed to confirm its efficacy for specific health outcomes.

Benefits

Pomegranate pericarp extract exhibits several evidence-based benefits. It demonstrates antioxidant activity in vitro and in animal models, with human studies showing increased plasma antioxidant capacity. Anti-inflammatory effects include a reduction in inflammatory markers like CRP and IL-6 in some human RCTs. Cardiometabolic benefits include lipid-lowering effects, with some human studies showing reductions in total cholesterol and LDL-C. In vitro and animal studies also suggest anticancer potential, particularly in prostate cancer models, though human clinical data are limited. These benefits are most pronounced in individuals with metabolic syndrome, cardiovascular risk, or inflammatory conditions. The antioxidant and anti-inflammatory effects are generally modest, while lipid-lowering effects may be clinically relevant in at-risk populations. Acute antioxidant effects are observed within hours, while metabolic and anti-inflammatory benefits may require weeks to months of supplementation.

How it works

Pomegranate pericarp extract exerts its effects through several biological pathways. It activates PPARγ, ABCA1, and CYP7A1 signaling pathways, leading to improved cholesterol metabolism. It also inhibits NF-κB and MMPs, contributing to its anti-inflammatory and anti-metastatic effects. The extract primarily affects the cardiovascular, metabolic, and inflammatory systems, with secondary effects on reproductive and gastrointestinal health. Key molecular targets include PPARγ, ABCA1, CYP7A1, NF-κB, MMP-2, MMP-9, Bcl-2, and Bax. The polyphenols, particularly punicalagins and ellagic acid, are absorbed but have variable bioavailability. Metabolites may also contribute to the systemic effects.

Side effects

Pomegranate pericarp extract is generally recognized as safe at typical doses, with adverse events being rare and mild. Common side effects include mild gastrointestinal discomfort, such as bloating or diarrhea, in some individuals. Uncommon side effects may include allergic reactions and headache. Rare side effects include severe allergic reactions and, in isolated case reports, hepatotoxicity. Potential drug interactions exist with CYP3A4 substrates, such as statins and calcium channel blockers, and there is a theoretical risk of increased bleeding with anticoagulants. It is contraindicated in individuals with a known allergy to pomegranate. Caution is advised in patients on anticoagulant therapy. Limited data are available regarding its use during pregnancy and lactation, so caution is recommended in these populations.

Dosage

The minimum effective dose of pomegranate pericarp extract is 100–200 mg/day of a standardized extract, typically containing 40% punicalagins. The optimal dosage range is 200–600 mg/day, depending on the specific formulation and the intended indication. A maximum safe dose of up to 1,000 mg/day has been used in short-term studies, but long-term safety data are limited. It can be taken with or without food, although absorption may be enhanced when taken with a meal. Standardized extracts are preferred for consistency, as whole fruit or juice may have different polyphenol profiles. Polyphenol absorption is variable, and co-administration with food may improve bioavailability. Adequate hydration is recommended.

FAQs

What is the best way to take pomegranate pericarp extract?

Standardized extracts are preferred for consistent dosing. Taking it with meals may enhance absorption. Follow the dosage recommendations on the product label or as advised by a healthcare professional.

Is pomegranate pericarp extract safe?

It is generally safe for most adults. Monitor for gastrointestinal symptoms or allergic reactions. Consult a healthcare provider if you have any concerns or are taking medications.

What are the expected benefits of taking this extract?

Modest improvements in antioxidant status, inflammation, and lipid profiles may be observed. Anticancer effects are not established in humans. Individual results may vary.

Can I get the same benefits from eating pomegranates?

While pomegranates are healthy, standardized extracts ensure consistent polyphenol content. Whole fruit or juice may not provide equivalent levels of the active compounds.

Are there any side effects I should be aware of?

Some individuals may experience mild gastrointestinal discomfort. Allergic reactions are rare but possible. Discontinue use and consult a healthcare provider if you experience any adverse effects.

Research Sources

  • https://pmc.ncbi.nlm.nih.gov/articles/PMC11563771/ – This systematic review of preclinical and clinical studies indicates that pomegranate pericarp extract has antioxidant, anti-inflammatory, and anticancer properties in vitro and in animal models. The review notes that human data are promising but limited, and highlights the need for more large, long-term human RCTs to confirm these findings.
  • https://www.mdpi.com/2075-1729/14/10/1264 – This study investigates the impact of pomegranate peel extract on gut microbiota and metabolic health. The findings suggest that pomegranate peel extract can modulate gut microbiota composition, potentially leading to improved metabolic outcomes. The study highlights the potential of pomegranate peel extract as a functional food ingredient for promoting gut health and metabolic well-being.
  • https://onlinelibrary.wiley.com/doi/10.1002/mnfr.70060?af=R – This systematic review focuses on preclinical evidence, showing that pomegranate extracts inhibit angiogenesis and tumor cell growth in cancer models. The review emphasizes that while the preclinical data are strong, there is limited translation to human outcomes, indicating a need for further clinical research.
  • https://www.spandidos-publications.com/10.3892/ijfn.2021.16 – This study explores the potential of pomegranate peel extract in managing obesity and related metabolic disorders. The findings suggest that pomegranate peel extract can modulate lipid metabolism, reduce inflammation, and improve insulin sensitivity. The study highlights the potential of pomegranate peel extract as a natural therapeutic agent for obesity and metabolic health.
  • https://pubs.acs.org/doi/10.1021/acsomega.3c02586 – This review of in vitro and animal studies reveals that pomegranate peel polyphenols improve cholesterol metabolism via PPARγ, ABCA1, and CYP7A1 pathways. The review notes that lipid-lowering effects have been observed in vitro and in some animal models, but emphasizes the need for more human clinical data to establish dose-response relationships.